North America Drug Delivery Market New Report by Data Bridge Market Research

North America Drug Delivery Market, By Route of Administration (Oral (Solid, Liquid, Semi-Solid), Injectable, Topical (Formulations, Transdermal Devices), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Centers, Others), By Distribution Channel (Direct Tenders, Hospital Pharmacies, Pharmacy Stores, Online Pharmacies), By Country (U.S., Canada, Mexico) – Trends and Forecast to 2024

Dallas, TX, December 01, 2016 --(PR.com)-- The market for Drug Delivery is expected to reach USD 814.4 billion by 2024 from USD 501.4 billion in 2016, growing at 6.4% during the forecast years to 2024.

The global infection control market is segmented on the basis of Route of Administration, end user, distribution channel, and geography.

Request for sample pages: http://databridgemarketresearch.com/reports/north-america-drug-delivery-market-trends-forecast-2024/

On the basis of route of administration the market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug. The solid drugs include and are categorized as tablets, capsules, powders and pills. The semi-solid drugs are further segmented into gels, emulsions and elixirs.

Based on end users the market is segmented into North America drug delivery market is segmented into hospitals, over the counter, ambulatory surgery centers/clinics, home care settings, diagnostic centers, and others.

On the basis of distribution channel the market is further segmented into Direct Tenders, Hospital Pharmacies, Pharmacy Stores, and Online Pharmacies.

Based on geography the market is segmented into 3 countries, U.S., Canada and Mexico.

Read more: http://databridgemarketresearch.com/reports/north-america-drug-delivery-market-trends-forecast-2024/

The major players operating in this market are Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc. , Merck & Co., Sanofi, Antares Pharma, 3M, Becton Dickinson and Company, Biolase, Inc., Cima Labs, Inc., West Pharmaceuticals, Antares Pharma, Alkermes, Foamis, Ypsomed, Skyepharma AG, Valeant Pharmaceuticals, DSM Biomedical and Catalent, Inc. among others.

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact
Data Bridge Market Research
Shubham Dwivedi
+1-888-387-2818
http://databridgemarketresearch.com/
Visit Data Bridge Blog @ http://databridgemarketresearch.com/blog/
ContactContact
Categories